While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Experts say the injections, which include semaglutide ... Co-author Dr Neil Iyengar added: “Reversing weight gain is important from a risk-reduction perspective to reduce the risk of recurrence ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

Retatrutide conferred the greatest weight reduction among all GLP-1s ... [because] currently all agents approved for weight loss are injections.” The results showed frequent adverse events ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.